SAFEs, Convertible Notes, and Series Seed: Legal Mechanics and Pitfalls

SAFEs (Simple Agreements for Future Equity), convertible notes, and Series Seed priced rounds represent three distinct legal structures for early-stage capital formation, each with a different risk allocation between founders and investors, a different treatment of valuation, and a different set of obligations that persist until a conversion or liquidity event resolves the instrument. The choice among them is not merely a matter of document simplicity or investor preference: it determines how the cap table behaves at the next financing, what regulatory compliance obligations arise immediately, and whether founders retain the ability to model their own dilution before issuing the next instrument.

This sub-article is part of the Venture Capital Financing: Legal Guide. It covers the legal mechanics of each instrument category in detail: the Y Combinator SAFE variants and how the 2018 shift from pre-money to post-money mechanics changed the dilution calculus for founders; MFN provisions and their stacking risk across a SAFE round; convertible note economic terms and the triggering events that govern conversion; Series Seed priced round documentation and its relationship to full NVCA preferred stock; founder dilution modeling under cap and discount interactions; the regulatory framework governing securities law compliance for convertible instruments; and the practical tools available to correct over-issuance and rescission exposure before a priced round.

Acquisition Stars advises founders, angel investors, and institutional seed investors on the structuring, negotiation, and documentation of convertible instrument rounds and Series Seed priced financings. Nothing in this article constitutes legal advice for any specific transaction.

Convertible Instrument Categories: An Overview

The landscape of early-stage convertible instruments divides into three categories that reflect different judgments about how much legal structure is appropriate for a financing of a given size and complexity. SAFEs occupy the simplest end of the spectrum: they are not debt instruments, they carry no maturity date, and they impose no interest obligation. They represent a contractual right to receive equity in a future priced round at a price determined by the conversion mechanics specified in the instrument. Convertible notes occupy the middle position: they are debt instruments with interest accrual, maturity dates, and conversion mechanics that parallel those of SAFEs, but with the additional creditor rights that debt instruments carry. Series Seed priced rounds occupy the most structured position: they issue preferred stock with defined rights, preferences, and protections that take effect immediately rather than at a future conversion event.

The practical question at each early-stage financing is whether the legal complexity of a more structured instrument is justified by the size of the round, the nature of the investor pool, and the company's need for defined rights on the cap table before the next financing. SAFEs are appropriate for small angels rounds where transaction cost efficiency matters more than cap table precision. Convertible notes are appropriate where investors require a debt instrument for their own regulatory or accounting reasons, or where the parties want interest accrual to compensate investors for the time value of money during the pre-priced-round period. Series Seed priced rounds are appropriate where the financing is large enough to justify the transaction cost, where institutional investors require a priced security, or where the founders want to establish a defined valuation anchor.

SAFE Variants: Y Combinator's Instrument and Its Iterations

Y Combinator introduced the original SAFE in late 2013 as a founder-friendly alternative to convertible notes, designed to eliminate the maturity date and interest accrual that create repayment risk for companies that do not raise a priced round on schedule. The original SAFE offered four variants: a cap-only SAFE, a discount-only SAFE, a SAFE with both a cap and a discount, and an uncapped MFN SAFE. Each variant defines a different economic relationship between the SAFE investor's conversion price and the priced round's per-share price.

The cap-only SAFE sets an upper limit on the valuation at which the investor converts: if the priced round is raised at a valuation above the cap, the investor converts as if the valuation were the cap, receiving more shares than new investors who invest at the full priced round valuation. The discount-only SAFE gives the investor a percentage reduction from the per-share price paid by new investors in the priced round, without reference to a specific dollar valuation. The cap-and-discount SAFE applies whichever mechanism produces the lower conversion price, giving the investor the most protective economic terms. The uncapped MFN SAFE carries no cap or discount but gives the investor the right to amend the instrument to match any more favorable terms offered in a subsequent SAFE issuance.

In 2018, Y Combinator replaced the original SAFE suite with a single post-money SAFE as the standard instrument, a change that fundamentally altered the dilution mechanics for both founders and investors. The original SAFEs were all pre-money instruments, which meant that the valuation cap was applied to the company's capitalization before the new money invested in the priced round. The post-money SAFE applies the cap to the company's capitalization including the SAFE itself but before the new priced round capital, which fixes the SAFE investor's ownership percentage at a known level at the time of signing. Understanding which version of the SAFE a company has issued, and whether the cap is a pre-money or post-money cap, is the starting point for any dilution analysis.

Pre-Money vs. Post-Money SAFE Mechanics

The mechanical difference between a pre-money and a post-money SAFE is most clearly understood by working through the dilution calculation for each at the time of a hypothetical priced round. In a pre-money SAFE with a $5 million valuation cap, the investor's conversion price is determined by dividing the $5 million cap by the company's fully diluted share count immediately before the priced round closes. That share count includes all outstanding common stock, all issued and outstanding options and warrants, all shares reserved in the option pool, and all other convertible instruments, but does not include the shares to be issued in the priced round or the shares to be issued on conversion of the SAFE itself. The pre-money SAFE investor's percentage ownership at conversion is therefore a function of the pre-round capitalization, which may be larger than the founders anticipated if the option pool has been expanded or additional SAFEs have been issued since the original SAFE was signed.

In a post-money SAFE with a $5 million valuation cap, the investor's ownership percentage is fixed at the time of signing as the investment amount divided by the cap. A $500,000 investment on a $5 million post-money cap produces a 10% ownership stake that is defined and knowable before the priced round. That 10% is calculated on a fully diluted post-money basis that includes all SAFEs outstanding at the time of the most recent SAFE issuance. When the company issues additional SAFEs after the first post-money SAFE, those additional SAFEs are included in the denominator used to calculate the first SAFE investor's conversion, which means that the first SAFE investor is diluted by subsequent SAFE issuances in the same way that all equity holders are diluted by new issuances. This is a significant departure from the pre-money SAFE, where all SAFE investors converted on the same pre-money denominator without diluting each other.

The founder's perspective on pre-money versus post-money mechanics is nuanced. Post-money SAFEs make dilution modeling more predictable because the ownership percentage at conversion is defined at signing. However, they also mean that each additional SAFE issuance dilutes all prior SAFE holders in a cascade that affects the founders only indirectly through the aggregate SAFE pool's impact on the cap table. Pre-money SAFEs create dilution uncertainty but do not require the founder to track the post-money denominator across multiple SAFE issuances. Companies that issue a large number of SAFEs across multiple closings over an extended period face the greatest dilution complexity regardless of which SAFE variant they use, because the interaction of multiple conversion events at the same priced round creates cap table dynamics that are difficult to model without dedicated equity management software.

SAFE MFN Provisions and Stacking Risk

The most-favored-nation provision in a SAFE gives the holder the right to amend the instrument to match the most favorable terms offered to any subsequent SAFE investor, typically during the period between the original SAFE issuance and the closing of the next priced round. MFN provisions are most commonly included in uncapped SAFEs issued to early investors who are willing to forgo a valuation cap in exchange for the assurance that they will receive at least as favorable terms as any investor who comes later. They also appear in capped SAFEs issued to investors who are concerned that the company may offer a lower cap to later investors who invest when the company's valuation is less certain.

MFN stacking risk arises when a company issues multiple SAFEs with MFN provisions and then offers progressively more favorable terms to subsequent investors. The first practical trigger of stacking risk occurs when the company issues a SAFE with a lower valuation cap to a later investor than the cap offered to an earlier MFN holder. The earlier holder's MFN right entitles it to amend its SAFE to adopt the lower cap, which increases its ownership at conversion. If the company then issues another SAFE to an even later investor with an even lower cap, and the earlier SAFE holders both have MFN rights, both holders can amend to the lowest cap in the stack, producing a conversion scenario where multiple investors all convert at the lowest cap offered to any investor, regardless of when they invested.

The legal complexity of MFN provisions increases when different SAFEs define "most favorable terms" differently. Some MFN clauses are triggered by any change to any economic term, including the discount rate, the valuation cap, and the conversion mechanics. Others are limited to changes in the valuation cap only. Still others exclude terms negotiated specifically for a single investor in consideration for that investor's non-economic obligations, such as board observer rights or pro rata rights, on the theory that a package negotiated in exchange for specific rights is not an apples-to-apples comparison with a SAFE that carries no such rights. The drafting of the MFN provision determines which subsequent SAFE issuances trigger the right and what terms the holder is entitled to receive, and ambiguous MFN language is a persistent source of conversion disputes at the Series A.

SAFE Valuation Cap and Discount: Interactions and Dilution Modeling

When a SAFE carries both a valuation cap and a conversion discount, the investor converts at the lower of the two prices, which corresponds to the more favorable economic outcome for the investor and the more dilutive outcome for the founders. Founders who model their dilution using only the cap without also modeling the discount scenario risk underestimating dilution in priced rounds where the round price is close to but above the cap.

The discount-based conversion price is calculated by taking the per-share price of the new securities issued in the priced round and multiplying it by one minus the discount percentage. A SAFE with a 20% discount converts at 80% of the Series A price per share. The cap-based conversion price is calculated by dividing the cap by the fully diluted share count at the time of conversion, in the manner specified by the SAFE's pre-money or post-money mechanics. If the cap-based price is lower than the discounted price, the SAFE converts at the cap. If the discounted price is lower, the SAFE converts at the discount.

The practical implication is that as the Series A valuation rises above the cap, the cap-based price remains constant while the discounted price rises proportionally with the round price. At a sufficiently high Series A valuation, the discounted price will eventually exceed the cap-based price, and the SAFE converts at the cap. However, in the range of valuations between the cap and a valuation high enough to make the discounted price exceed the cap price, the discount can produce a lower conversion price than the cap. Founders should build a valuation sensitivity table that computes the SAFE conversion price under both mechanisms across a range of plausible Series A valuations before the Series A negotiation begins.

Convertible Note Terms: Interest, Maturity, Discount, and Cap

A convertible note is a promissory note that combines the economic terms of debt, including an interest rate, a maturity date, and a principal repayment obligation, with conversion mechanics that allow the debt to convert into equity upon specified triggering events. The interest rate on a convertible note is typically set between 4% and 8% per annum, calculated on a simple interest basis, and accrues from the date of issuance until conversion or repayment. The accrued interest converts along with the principal at the time of the qualified financing, increasing the total amount of conversion proceeds and correspondingly increasing the number of shares issued to the noteholder.

The maturity date is the date by which the note must either convert or be repaid. Maturity dates in early-stage convertible notes are typically set 18 to 24 months from the date of issuance, reflecting the founders' estimate of the time required to close a priced round. A company that fails to close a qualified financing before the maturity date faces a choice between repaying the note at par plus accrued interest, which may be impossible if the company does not have sufficient cash, or negotiating an amendment with the noteholder to extend the maturity date or modify the conversion terms. Noteholders who are not willing to amend have the contractual right to demand repayment at maturity, which can precipitate a default that accelerates all outstanding notes simultaneously if the note purchase agreement includes a cross-default provision.

The conversion discount and valuation cap in a convertible note function mechanically the same way as in a SAFE: the discount reduces the conversion price relative to the priced round price, the cap sets a ceiling on the conversion valuation, and the investor converts at whichever produces the lower price. The primary difference from a SAFE is that the note's principal and accrued interest together determine the total amount converting, so the number of shares issued on conversion is higher than it would be for a SAFE of the same original principal amount by the amount of accrued interest.

Note Triggering Events: Qualified Financing, Change of Control, and Dissolution

The triggering events in a convertible note determine when the debt converts to equity and on what terms. The most important triggering event is the qualified financing, defined as an equity financing that meets a specified minimum gross proceeds threshold. When a qualified financing occurs, the note typically converts automatically at the lower of the discounted price or the cap price, and the noteholder receives the same class of preferred stock issued to investors in the qualified financing. The minimum threshold for a qualified financing is one of the most negotiated terms in a convertible note, because it determines whether a given priced round causes automatic conversion or whether the noteholder retains the right to demand repayment or negotiate separate conversion terms.

The change-of-control triggering event addresses what happens if the company is acquired before a qualified financing occurs. Most convertible notes give the noteholder the right to either convert the note into common stock at the cap price and participate in the acquisition as an equity holder, or receive repayment of the note at a specified premium, commonly expressed as a multiple of the outstanding principal and accrued interest. The choice of premium is significant: a 2x repayment premium on a note that has not yet reached maturity may produce a better outcome for the noteholder than conversion at the cap price if the acquisition price is below the cap, because the repayment premium gives the noteholder a defined return without exposure to the acquisition proceeds distribution mechanics.

The dissolution or wind-down scenario addresses what happens if the company fails and its assets are distributed to creditors and equity holders. Because convertible notes are debt instruments, noteholders have creditor priority over equity holders in a dissolution, which means they are entitled to repayment of principal and accrued interest before any proceeds are distributed to common stockholders or SAFE holders. SAFE holders, as non-debt instrument holders, have priority over common stockholders but may be junior to noteholders depending on the specific terms of the SAFE and the note purchase agreement. Companies that have both SAFEs and convertible notes outstanding must understand the relative priority of each instrument class in a dissolution to assess the true risk profile of each.

Most Favored Nation on Convertible Notes

MFN provisions in convertible notes function similarly to those in SAFEs but with the additional complexity that a convertible note's economic terms include both the debt terms and the conversion terms. An MFN in a convertible note may be limited to conversion economics, in which case a subsequent note with a lower cap or higher discount triggers the right. Alternatively, a broadly drafted MFN may extend to all material economic terms, including the interest rate, the maturity date, and any conversion premium applicable upon a change of control.

The stacking risk from MFN provisions in a convertible note round is amplified by the interaction of accrued interest with conversion mechanics. If the company issues a later note with a lower cap that triggers earlier noteholders' MFN rights, those earlier noteholders amend their notes to adopt the lower cap and then continue accruing interest on their original principal until conversion. The result is that the earlier noteholders convert more principal plus more accrued interest at a lower cap, producing a larger number of shares than the company modeled when it set the cap on the later note.

One practical approach to managing MFN risk in a note round is to structure the note purchase agreement to permit the company to issue subsequent notes with different terms without triggering existing MFN provisions, provided that the aggregate amount of notes issued at the more favorable terms does not exceed a specified threshold. This carve-out allows the company to accommodate a single strategic investor who negotiates specific terms without opening the entire note stack to a cascade of MFN amendments. Whether this carve-out is acceptable to existing noteholders depends on the size of the carve-out threshold and the nature of the investor who benefits from the more favorable terms.

Series Seed Priced Round: Documents and Structure

A Series Seed priced round issues preferred stock at a defined pre-money valuation, converts all outstanding SAFEs and convertible notes into the same or a related series of preferred stock, and establishes the company's cap table with known share counts and ownership percentages for all investor classes. The document set for a Series Seed round is substantially smaller than the full NVCA preferred stock suite used in a Series A: it typically consists of a Series Seed Preferred Stock Purchase Agreement, an amended and restated certificate of incorporation, and either a simplified investor rights agreement or a set of rights included directly in the certificate. The National Venture Capital Association and Cooley LLP, among others, have published simplified Series Seed document templates that compress the full preferred stock document suite into a smaller set of shorter agreements.

The Series Seed Preferred Stock Purchase Agreement covers the basic economics of the round: the pre-money valuation, the per-share price, the number of shares to be issued, the representations and warranties made by the company and the founders, and the closing conditions. It is substantially shorter than a Series A SPA because it omits many of the investor protection provisions, including the more extensive representations and warranties, the indemnification provisions, and the closing conditions, that institutional venture investors require in a Series A round. The abbreviated nature of the document reflects the smaller investment size and the different risk profile of a seed-stage investment.

The amended and restated certificate of incorporation creates the Series Seed Preferred Stock as a new class of stock with defined rights, preferences, and protections. Those rights are significantly simplified relative to Series A preferred: the liquidation preference is typically non-participating with a 1x preference, dividends are non-cumulative and declared only if and when the board authorizes them, conversion rights allow the holder to convert to common stock at any time on a one-for-one basis, and protective provisions give the Series Seed holders a class vote on a defined list of actions, including amendments to the certificate that would adversely affect the Series Seed holders, any authorization of a new series of preferred stock senior to the Series Seed, and any merger or sale of the company below specified parameters.

Simple Series Seed vs. Full Preferred Stock: Rights Comparison

The primary differences between a simple Series Seed preferred stock and the full preferred stock issued in a Series A are the liquidation preference structure, the anti-dilution protection, the registration rights, and the information and inspection rights. Understanding these differences is important both for founders who are deciding whether to offer a priced Series Seed or additional SAFEs, and for institutional investors who are evaluating whether Series Seed preferred stock provides adequate protection for their investment.

Series Seed preferred stock typically carries a non-participating liquidation preference at 1x the original issue price. This means that in a sale or liquidation, the Series Seed holders receive their original investment back before any proceeds are distributed to common stockholders, but they do not participate further in the proceeds after receiving their preference. They may convert to common and participate in the proceeds as common stockholders if the common stock value exceeds the preference, but they cannot receive both the preference and a pro-rata share of the remaining proceeds. Series A preferred stock in a traditional NVCA structure may be participating or non-participating depending on what is negotiated, and participating preferred can produce materially better outcomes for investors in moderate-valuation exit scenarios.

Series Seed preferred stock does not typically include anti-dilution protection in the same form as Series A preferred. Some simplified Series Seed documents include a basic anti-dilution adjustment that converts the preferred on a standard conversion ratio if the company issues stock below the Series Seed issue price, but the anti-dilution provisions are simpler than the broad-based weighted average formula used in Series A documents and do not cover the full range of dilutive issuances that a sophisticated investor would want captured. This difference is relevant when the Series Seed holders convert into Series A preferred at the Series A: the conversion ratio must be carefully computed to reflect any anti-dilution adjustments that have accrued during the Series Seed period.

Founder Dilution Modeling: Cap vs. Discount Interactions

The most consequential analytical exercise for founders managing a convertible instrument round is building a dilution model that captures the interaction of all outstanding SAFEs and convertible notes across a range of plausible Series A valuations. The model must account for each instrument's conversion mechanics, the applicable pre-money or post-money SAFE variant, the cap and discount applicable to each instrument, the accrued interest on outstanding convertible notes, and the option pool expansion that is typically required before a Series A closes.

The basic structure of a dilution model runs as follows. For each outstanding SAFE, compute the conversion price under both the cap and the discount at each modeled Series A valuation, and assign the lower price. Divide the SAFE investment amount by the conversion price to determine the number of conversion shares. Repeat this calculation for each outstanding convertible note, using principal plus accrued interest as the conversion amount. Sum the conversion shares across all instruments. Add the Series A shares to be issued at the Series A price to raise the desired capital. Add the option pool shares to be added before the Series A closes. Divide each investor group's shares by the total fully diluted share count after all of the above to determine post-Series A ownership percentages.

Founders who run this model for the first time before a Series A term sheet arrives frequently discover that the aggregate dilution from outstanding SAFEs and notes is larger than they estimated when those instruments were issued, because the model captures interactions that are not visible when analyzing each instrument in isolation. The most common sources of this surprise dilution are the MFN cascade across multiple instruments, the accrued interest on convertible notes that has compounded over a longer-than-anticipated pre-Series A period, and the impact of option pool expansion on the denominator used for pre-money SAFE conversions. Running the model before beginning Series A discussions allows founders to identify and address any cleanup issues while they still have time to negotiate them outside the pressure of a live term sheet.

Common Pitfalls: Over-Issuance, Missed Conversions, and Cap Table Errors

The most common legal pitfalls in convertible instrument rounds fall into three categories: over-issuance of convertible instruments that collectively represent more dilution than the founders intended or than the company's authorized share count can absorb at conversion; missed or incorrect conversion mechanics that produce cap table errors at the Series A; and regulatory compliance failures that create rescission risk.

Over-issuance occurs when a company issues so many SAFEs and convertible notes that the aggregate conversion shares would exceed the company's authorized preferred share count at the time of a Series A, or would represent a percentage of the post-conversion cap table that makes a Series A negotiation impractical. Companies that issue multiple SAFEs across an extended pre-Series A period frequently do not maintain a running dilution model, and the aggregate dilution from the full SAFE stack only becomes apparent when a Series A investor requests a fully diluted capitalization table. By that point, correcting the over-issuance requires either amending outstanding instruments with investor consent, increasing the authorized share count, or restructuring the SAFE stack, all of which take time and create legal complexity that can delay or derail the Series A.

Missed or incorrect conversions are a distinct problem that arises at the closing of the qualified financing. SAFE and note conversion is often handled manually rather than by automated equity management software, and errors in the calculation of conversion prices, accrued interest, or option pool adjustments can produce an incorrect cap table that must be restated after closing. A restated cap table creates fiduciary exposure for the board and potential disputes with investors who believe the corrected conversion produces fewer shares than they were promised. The correct approach is to engage counsel to prepare a conversion waterfall analysis before the Series A closes and to have the analysis reviewed by each converting instrument holder before they sign the conversion documents.

Regulatory Treatment: Reg D, Blue Sky, and Rescission Risk

SAFEs and convertible notes are securities subject to the registration requirements of the Securities Act of 1933 unless an exemption applies. The exemption most commonly relied upon for early-stage convertible instrument rounds is Rule 506 of Regulation D, which provides a safe harbor from the registration requirement for offerings that satisfy specified conditions regarding investor eligibility, manner of offering, and disclosure. Rule 506(b) allows sales to an unlimited number of accredited investors and up to 35 non-accredited but sophisticated investors, provided no general solicitation or advertising is used. Rule 506(c) allows general solicitation but requires that all purchasers be accredited investors and that the company take reasonable steps to verify their accredited investor status before the sale.

The federal Regulation D exemption does not preempt state securities law registration requirements with respect to filing obligations. States that are not preempted by the National Securities Markets Improvement Act for Rule 506 offerings still require notice filings, and most states require a Form D filing along with a state notice filing and a fee payment within a specified period after the first sale in the state. The deadlines for state notice filings vary by state but are typically 15 to 30 days from the first sale, and failure to file on time can result in the state's securities administrator demanding rescission of the sale as a remedy.

Rescission risk is the practical consequence of securities law noncompliance: an investor who purchased securities in violation of applicable securities law may have the right to demand rescission of the purchase, requiring the company to return the investor's money with interest. In the SAFE and convertible note context, rescission risk arises most commonly from failure to file timely Regulation D Form D with the SEC, failure to make required state notice filings, failure to verify accredited investor status under Rule 506(c), or use of general solicitation in a Rule 506(b) offering. Rescission risk that has not been resolved before a Series A will delay or block the closing, because the Series A investor will require a legal opinion that the outstanding SAFEs and notes were issued in compliance with applicable securities law.

Practical cures for rescission risk depend on the nature of the violation and the applicable state law. For federal Form D filing failures, the cure typically involves filing the Form D as promptly as possible after discovery of the failure, which does not eliminate the violation but demonstrates good faith compliance and reduces the practical risk of SEC enforcement. For state notice filing failures, many states have rescission cure provisions that allow the company to make a rescission offer to the affected investors and, if no investor accepts the offer, treat the rescission risk as resolved. Legal counsel should be engaged to assess the specific violations, identify the applicable cure provisions in each state, and prepare the rescission offer if required.

Frequently Asked Questions